Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.5080
-0.0918 (-15.31%)
At close: Oct 15, 2026, 4:00 PM EDT
0.5022
-0.0058 (-1.14%)
After-hours: Oct 15, 2026, 7:56 PM EDT
Curis Market Cap
Curis has a market cap or net worth of $1.06 million as of October 15, 2026. It is the 49,320th most valuable company in the world and the 6,713th biggest in the United States. Its market cap has decreased by 94.13% in one year.
Market Cap
1.06M
Enterprise Value
-2.97M
1-Year Change
-94.13%
Global Rank
Country Rank
#6,713 United States
Category
ChartMarket Cap Chart
Since August 1, 2000, Curis's market cap has decreased from $613.20M to $1.06M, a decrease of -99.83%. That is a compound annual growth rate of -21.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 1.30M | -89.84% |
| Dec 31, 2025 | 12.80M | -50.58% |
| Dec 31, 2024 | 25.90M | -65.47% |
| Dec 29, 2023 | 75.00M | 41.51% |
| Dec 30, 2022 | 53.00M | -87.85% |
| Dec 31, 2021 | 436.10M | -9.47% |
| Dec 31, 2020 | 481.70M | 754.08% |
| Dec 31, 2019 | 56.40M | 147.37% |
| Dec 31, 2018 | 22.80M | -80.14% |
| Dec 29, 2017 | 114.80M | -73.48% |
| Dec 30, 2016 | 432.90M | 15.87% |
| Dec 31, 2015 | 373.60M | 189.61% |
| Dec 31, 2014 | 129.00M | -46.69% |
| Dec 31, 2013 | 242.00M | -11.78% |
| Dec 31, 2012 | 274.30M | -23.47% |
| Dec 30, 2011 | 358.40M | 139.25% |
| Dec 31, 2010 | 149.80M | -30.74% |
| Dec 31, 2009 | 216.30M | 354.41% |
| Dec 31, 2008 | 47.60M | -23.10% |
| Dec 31, 2007 | 61.90M | -0.16% |
| Dec 29, 2006 | 62.00M | -64.71% |
| Dec 30, 2005 | 175.70M | -28.84% |
| Dec 31, 2004 | 246.90M | 36.11% |
| Dec 31, 2003 | 181.40M | 438.28% |
| Dec 31, 2002 | 33.70M | -81.39% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genprex | 1.96M |
| Oragenics | 1.94M |
| Silo Pharma | 1.92M |
| BioRestorative Therapies | 1.90M |
| Lakewood-Amedex Biotherapeutics | 1.64M |
| Artelo Biosciences | 1.55M |
| Virax Biolabs Group | 1.34M |
| Valion Bio | 1.32M |